Dai Yingdi, Ma Sijia, Zhu Yanyan, Gontcharov Andrey A, Liu Yang, Wang Qi
Engineering Research Center of Chinese Ministry of Education for Edible and Medicinal Fungi, Jilin Agricultural University, Changchun 130118, China.
College of Plant Protection, Jilin Agricultural University, Changchun 130012, China.
Molecules. 2023 Aug 2;28(15):5825. doi: 10.3390/molecules28155825.
fermentation extract (FREP) was obtained by ethanol precipitation of the fermentation broth. The molecular weight of FREP is 28.52 kDa, and it mainly contains active ingredients such as polysaccharides, proteins, reducing sugars, and 16 amino acids. Among them, the polysaccharides were mannose, glucose, galactose, arabinose, and fucose and possessed β-glycosidic bonds. Furthermore, the immunoregulatory activities of FREP were investigated in vivo. The results demonstrated that FREP could increase the counts of CD T lymphocytes and the ratio of CD/CD in a dose-dependent manner in healthy mice. In addition, FREP significantly increased serum cytokines, including IL-2, IL-8, IL-10, IL-12, IL-6, IL-1β, INF-γ, C-rection protein, and TNF-α, and promoted splenocyte proliferation in healthy mice. Finally, FREP could restore the counts of white blood cells, red blood cells, secretory immunoglobulin A, and antibody-forming cells and significantly promote the serum haemolysin level in mice treated with cyclophosphamide. The findings indicated that FREP possessed immunoregulatory activity in healthy mice and could improve the immune functions in immunosuppressive mice. Therefore, FREP could be exploited as an immunomodulatory agent and potential immunotherapeutic medicine for patients with inadequate immune function.
发酵提取物(FREP)通过对发酵液进行乙醇沉淀获得。FREP的分子量为28.52 kDa,主要含有多糖、蛋白质、还原糖和16种氨基酸等活性成分。其中,多糖为甘露糖、葡萄糖、半乳糖、阿拉伯糖和岩藻糖,并具有β-糖苷键。此外,还在体内研究了FREP的免疫调节活性。结果表明,FREP能以剂量依赖的方式增加健康小鼠体内CD T淋巴细胞计数以及CD/CD比值。此外,FREP显著增加了健康小鼠血清中的细胞因子,包括白细胞介素-2、白细胞介素-8、白细胞介素-10、白细胞介素-12、白细胞介素-6、白细胞介素-1β、干扰素-γ、C反应蛋白和肿瘤坏死因子-α,并促进了脾细胞增殖。最后,FREP能恢复环磷酰胺处理小鼠的白细胞、红细胞、分泌型免疫球蛋白A和抗体形成细胞计数,并显著提高血清溶血素水平。这些发现表明,FREP在健康小鼠中具有免疫调节活性,并能改善免疫抑制小鼠的免疫功能。因此,FREP可被开发为一种免疫调节药物,用于免疫功能不足的患者,作为潜在的免疫治疗药物。